Final report of phase II study of sorafenib, cytarabine and idarubicin for initial therapy in younger patients with acute myeloid leukemia.
| Autor: | Ravandi, F1, Arana Yi, C1, Cortes, J E1, Levis, M2, Faderl, S1, Garcia-Manero, G1, Jabbour, E1, Konopleva, M1, O'Brien, S1, Estrov, Z1, Borthakur, G1, Thomas, D1, Pierce, S1, Brandt, M1, Pratz, K2, Luthra, R3, Andreeff, M1, Kantarjian, H1 |
|---|---|
| Zdroj: | Leukemia (08876924). Jul2014, Vol. 28 Issue 7, p1543-1545. 3p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|